Financial Times Letter to the Editor

Superbugs threaten the longevity miracle


Your editorial “War on superbugs must follow defeat of Covid-19” (FT View, December 29) is exactly right on the facts, but misses three powerful if subtle points.

First, the antimicrobial resistance (AMR) crisis is already here especially for older adults, who will number 2bn by mid-century and represent increasingly larger proportions of societies at risk in countless under-reported ways.

For example, hip, knee and heart valve replacements, cancer therapy or simple hospital visits are already avoided due to the greater risk of untreatable, often deadly infections.

Second, while the policy reforms in the US Pasteur Act are essential this must be replicated in the UK, across Europe and in Japan so that there re-emerges a truly global marketplace for the antibiotic innovation we so desperately want to enable.

Third, while to inner circle elites the AMR threat might well have been “rising up the global health priorities pre-Covid-19”, it has neither been recognised as the profound economic threat we now understand from Covid-19, nor entered the daily social and popular media.

Yes, the antibiotic revolution along with improved sanitation of the mid-20th century largely fuelled today’s longevity miracle of life to 100 as a matter of course. Antibiotics enabled billions to live past birth and early infancy and cured deadly infections as we aged.

How ironic as 2021 launches the UN/World Health Organization Decade of Healthy Ageing that one of the central reasons for our 20th century longevity miracle — antibiotics — is now threatened to extinction.

Michael W. Hodin
Chief Executive of the Global Coalition on Ageing,
Managing Partner High Lantern Group,
Regent at Harris Manchester College, Oxford University, UK

Source: Financial Times

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

What Old Age Might Be Like for Today’s 30-Year-Olds

Get ready for a new old age. With the U.S. fertility rate in a decadelong slump and the life expectancy of 65-year-old Americans approaching roughly 85, our aging nation is likely to grow older by midcentury, as the ratio of young to old continues to decline. The trend is likely to upend how our society is organized, making life very different for today’s 30-year-olds when they reach their 60s compared with life for 60-year-olds now.

World Population Reaches 8bn As It Grows Older

The world’s population reached 8bn people on Tuesday and will hit 9bn in 15 years as it experiences an unprecedented surge in the number of older people, according to the latest UN data. The global fertility rate has more than halved since the 1950s to 2.3 births per woman. With mortality also falling, the number of people aged 65 and over is expected to rise from 783mn in 2022 to 1bn by 2030 and reach 1.4bn by 2043, the UN population data revealed.

Global Coalition on Aging (GCOA) Launches Cross-Sector Alliance Committed to Health Innovation at High-Level Forum on The Silver Economy

Today, the Global Coalition on Aging (GCOA), along with cross-sector stakeholders representing patient advocacy, policy, industry, and academic communities, announced the launch of the Alliance for Health Innovation at the High-Level Forum on the Silver Economy in New York. The Alliance is dedicated to establishing the importance of innovation in achieving healthy aging and health equity through investments, policy reforms, and strategic partnerships.

Japan Must Face Up to Growing Danger of Drug-resistant Germs

In the wake of more than 6.4 million COVID-19 deaths worldwide and unprecedented economic destruction, the global community has no excuse to be caught unprepared for the next pandemic. Yet right now, a devastating parallel plague is already underway and worsening. Some years, it is killing well over 1 million people, according to medical journal The Lancet.

A Bipartisan Bill Could Prevent The Next Pandemic

In Washington, Republicans and Democrats are typically at loggerheads when it comes to healthcare policy. Just consider the recent Inflation Reduction Act, which made extensive changes to Medicare and also extended Affordable Care Act subsidies. Every single congressional Democrat voted for the legislation, while every single member of the GOP voted against it. But occasionally, a bill is such an obviously good idea, and so desperately needed, that it commands significant bipartisan support. The PASTEUR Act, co-sponsored by 31 Democrats and 31 Republicans in the House and two members of each party in the Senate, is just such a bill.

Korea Must Act Now to Combat Growing AMR Threat

Public officials are overlooking one of the gravest long-term threats to the Korean people, the health system, and economy: antimicrobial resistance (AMR). Some pathogens ― bacteria, fungi, parasites, and viruses ― have evolved strains that resist the antimicrobial medications we currently have available to fight them. Health care professionals often must watch helplessly as patients succumb to infections that antibiotics could once have easily beaten. They know that new antimicrobials, including and especially antibiotics, could easily gain the victory ― but they have none at their disposal.

Policy Statement on the Impact of Price Negotiations on Innovation, Healthy Aging and Equity

As the CEO of the Global Coalition on Aging (GCOA) and a newly formed cross-sector Alliance for Health Innovation, we write to express our deep concern with the current legislation that allows for price “negotiations” in Medicare – a thinly veiled signal for America’s plunge into price controls that will have a devastating and adverse impact on biopharmaceutical innovation and our nations’ ability to support healthy aging.